VCM
BLFS icon

Versant Capital Management’s BioLife Solutions BLFS Stock Holding History

Versant Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Buy
498
+42
+9% +$982 ﹤0.01% 2106
2026
Q1 		$8.7K Sell
456
-370
-45% -$8.18K ﹤0.01% 2192
2025
Q4 		$20K Hold
826
– – ﹤0.01% 1642
2025
Q3 		$21.1K Sell
826
-484
-37% -$11.5K ﹤0.01% 1552
2025
Q2 		$28.2K Buy
1,310
+1,170
+836% +$26.4K ﹤0.01% 1321
2025
Q1 		$3.2K Buy
140
+44
+46% +$1.16K ﹤0.01% 2185
2024
Q4 		$2.49K Buy
96
+15
+19% +$373 ﹤0.01% 2003
2024
Q3 		$2.03K Buy
+81
New +$1.91K ﹤0.01% 1557

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Versant Capital Management's BLFS Position: Q2 2026 in Review

Versant Capital Management increased its BioLife Solutions (BLFS) stake by 9.2% in Q2 2026, buying an estimated $982 and bringing the position to 498 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Versant Capital Management first reported a position in BLFS in Q3 2024 and has held it in 8 quarters since. The position peaked at $28.2K in Q2 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Versant Capital Management held 498 shares of BioLife Solutions worth $14.1K as of Q2 2026.
  • Versant Capital Management bought 42 BioLife Solutions shares in Q2 2026, an estimated $982.
  • BioLife Solutions made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2106 holding.
  • Versant Capital Management first reported a position in BioLife Solutions in Q3 2024 and has held it in 8 quarters since.
  • Versant Capital Management's BioLife Solutions position peaked at $28.2K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.